Cas:101219-69-6 Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) manufacturer & supplier

Chemical Name:Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI)

CAS.NO:101219-69-6

Synonyms:Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI)

Molecular Formula:C₉H₉NO

Molecular Weight:147.17400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:291.337ºC at 760 mmHg

Density:1.124 g/cm3

Index of Refraction:1.556

PSA:44.02000

Exact Mass:147.06800

LogP:1.61158

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) Use and application,Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) technical grade,usp/ep/jp grade.

Related News: In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape. Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) manufacturer Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) supplier In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) vendor As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. Benzonitrile, 4-[(1R)-1-hydroxyethyl]- (9CI) factory Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.